Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. TR Fuerst, EG Niles, FW Studier, B Moss Proceedings of the National Academy of Sciences 83 (21), 8122-8126, 1986 | 2596 | 1986 |
Poxviridae: the viruses and their replication. B Moss | 1534 | 2001 |
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine RR Amara, F Villinger, JD Altman, SL Lydy, SP O'Neil, SI Staprans, ... Science 292 (5514), 69-74, 2001 | 1436 | 2001 |
HIV-specific cytotoxic T lymphocytes in seropositive individuals BD Walker, S Chakrabarti, B Moss, TJ Paradis, T Flynn, AG Durno, ... Nature 328 (6128), 345-348, 1987 | 1046 | 1987 |
Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques S Chakrabarti, K Brechling, B Moss Molecular and cellular biology 5 (12), 3403-3409, 1985 | 995 | 1985 |
Vaccinia virus: a selectable eukaryotic cloning and expression vector. M Mackett, GL Smith, B Moss Proceedings of the National Academy of Sciences 79 (23), 7415-7419, 1982 | 986 | 1982 |
Nonreplicating vaccinia vector efficiently expresses recombinant genes. G Sutter, B Moss Proceedings of the National Academy of Sciences 89 (22), 10847-10851, 1992 | 850 | 1992 |
General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes M Mackett, GL Smith, B Moss Journal of virology 49 (3), 857-864, 1984 | 850 | 1984 |
In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity RL Willey, DH Smith, LA Lasky, TS Theodore, PL Earl, B Moss, DJ Capon, ... Journal of virology 62 (1), 139-147, 1988 | 846 | 1988 |
Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. B Moss Proceedings of the National Academy of Sciences 93 (21), 11341-11348, 1996 | 832 | 1996 |
Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein JD Lifson, MB Feinberg, GR Reyes, L Rabin, B Banapour, S Chakrabarti, ... Nature 323 (6090), 725-728, 1986 | 779 | 1986 |
Methylated nucleotides block 5′ terminus of HeLa cell messenger RNA CM Wei, A Gershowitz, B Moss Cell 4 (4), 379-386, 1975 | 769 | 1975 |
Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. JW Yewdell, JR Bennink, GL Smith, B Moss Proceedings of the National Academy of Sciences 82 (6), 1785-1789, 1985 | 689 | 1985 |
The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. B Rehermann, P Fowler, J Sidney, J Person, A Redeker, M Brown, ... The Journal of experimental medicine 181 (3), 1047-1058, 1995 | 642 | 1995 |
New mammalian expression vectors B Moss, O Elroy-Stein, T Mizukami, WA Alexander, TR Fuerst Nature 348 (6296), 91-92, 1990 | 635 | 1990 |
Vaccinia virus: a tool for research and vaccine development B Moss Science 252 (5013), 1662-1667, 1991 | 626 | 1991 |
Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen GL Smith, M Mackett, B Moss Nature 302 (5908), 490-495, 1983 | 626 | 1983 |
Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype RML Buller, GL Smith, K Cremer, AL Notkins, B Moss Nature 317 (6040), 813-815, 1985 | 606 | 1985 |
A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses FKM Chan, J Shisler, JG Bixby, M Felices, L Zheng, M Appel, J Orenstein, ... Journal of Biological Chemistry 278 (51), 51613-51621, 2003 | 605 | 2003 |
Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas-and TNFR1-induced apoptosis J Bertin, RC Armstrong, S Ottilie, DA Martin, Y Wang, S Banks, GH Wang, ... Proceedings of the National Academy of Sciences 94 (4), 1172-1176, 1997 | 603 | 1997 |